Skip to main content

Table 5 Parameters for analytical method development for in vivo estimation of trospium chloride

From: Development, optimization and pharmacokinetic evaluation of biphasic extended-release osmotic drug delivery system of trospium chloride for promising application in treatment of overactive bladder

 

Chromatographic specifications

Mass spectrometric specifications

1

Stationary Phase

Zorbax SB C18, 75 × 2.1 mm, 3.5 µm with guard column

MRM transition (amu)

392.2 > 182

2

Mobile Phase

Mixture of Buffer: Organic mixture (20:80; v/v)

Declustering potential (V)

120

3

Organic mixture

Acetonitrile: Methanol (95:5; v/v)

Entrance potential (V)

8

4

Flow rate

0.3 mL/min

Collision energy (V)

41

5

Auto-injector temperature

5 ± 1 °C

Collision cell exit potential (V)

8

6

Column temperature

30 ± 1 °C

Dwell time (ms)

300

7

Injection volume

5 µL

 

 -

8

Run time

3.5 min

 -

 -

9

Detector

Triple quadrupole mass spectrometer

 -

 -